Commentary & Perspectives

Five Ways AI Will Reshape Life Sciences in 2026

Why people, process, and purpose matter most

Share

The life sciences industry is transitioning to a new phase of AI adoption, moving away from hype-driven initiatives towards strategic applications that enhance therapy development and delivery. In 2026, organizations will focus on embedding AI into operations through people and process transformation. This shift will include industry-specific AI to streamline commercial connections, the agility of dynamic data for launch success, and enhanced clinical trial data flow to improve recruitment and patient experience. The emphasis will be on responsible AI deployment to unlock its full potential.

Original Source(s)

Five Ways AI Will Reshape Life Sciences in 2026

Why people, process, and purpose matter most

  • by Chris Moore

  • February 5, 2026

  • 6 min

Related Content

Plasma pTau217 Cutoffs for Clinical Use

Researchers assess how biological factors influence plasma biomarker interpretation for amyloid detection.

Who Decides When a Doctor Steps Back?

Cognitive decline, credentialing, and why “I’ll know” often isn’t enough.

Unexpected Finds After Routine Procedures

Two patients presented months after minimally invasive facial procedures with persistent findings that ultimately revealed retained foreign bodies, according to a recent case series.